← Evidence map

ArticleThe Journal of clinical investigation2014

Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm.

Guangyao Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

36 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24812670